Found: 80
Select item for more details and to access through your institution.
CD38 is methylated in prostate cancer and regulates extracellular NAD<sup>+</sup>.
- Published in:
- Cancer & Metabolism, 2018, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40170-018-0186-3
- By:
- Publication type:
- Article
Multimodality Therapies for Localized Prostate Cancer.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 3, p. 221, doi. 10.1007/s11912-023-01374-9
- By:
- Publication type:
- Article
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance.
- Published in:
- Nature Medicine, 2010, v. 16, n. 12, p. 1414, doi. 10.1038/nm.2236
- By:
- Publication type:
- Article
Titelbild: Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers (Angew. Chem. 13/2011).
- Published in:
- Angewandte Chemie, 2011, v. 123, n. 13, p. 2909, doi. 10.1002/ange.201100624
- By:
- Publication type:
- Article
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers.
- Published in:
- Angewandte Chemie, 2011, v. 123, n. 13, p. 3140, doi. 10.1002/ange.201005853
- By:
- Publication type:
- Article
c-Crk proto-oncogene contributes to transcriptional repression of p120- catenin in non-small cell lung cancer cells.
- Published in:
- Clinical & Experimental Metastasis, 2011, v. 28, n. 4, p. 391, doi. 10.1007/s10585-011-9378-8
- By:
- Publication type:
- Article
Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging study.
- Published in:
- EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-01048-4
- By:
- Publication type:
- Article
Quantitative Magnetic Separation of Particles and Cells Using Gradient Magnetic Ratcheting.
- Published in:
- Small, 2016, v. 12, n. 14, p. 1891, doi. 10.1002/smll.201502120
- By:
- Publication type:
- Article
Ordering and Interpreting Precision Oncology Studies for Adults With Advanced Solid Tumors: A Primer.
- Published in:
- Federal Practitioner, 2022, v. 39, p. S16, doi. 10.12788/fp.0270
- By:
- Publication type:
- Article
PAK1 Kinase Promotes Cell Motility and Invasiveness through CRK-II Serine Phosphorylation in Non-Small Cell Lung Cancer Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0042012
- By:
- Publication type:
- Article
(S045) Specialty Biases Influence Recommended Treatment Strategies for Patients With High-Risk Prostate Cancer: A Patterns-of-Care Study.
- Published in:
- Oncology (08909091), 2016, p. 23
- By:
- Publication type:
- Article
Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center study.
- Published in:
- European Journal of Hybrid Imaging, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41824-023-00178-1
- By:
- Publication type:
- Article
Quantitative assessment of PSMA PET response to therapy in castration-sensitive prostate cancer using an automated imaging platform for disease identification and measurement.
- Published in:
- European Journal of Hybrid Imaging, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41824-023-00165-6
- By:
- Publication type:
- Article
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 12, p. e2139769, doi. 10.1001/jamanetworkopen.2021.39769
- By:
- Publication type:
- Article
Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapy.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-75589-6
- By:
- Publication type:
- Article
Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 1, p. 105, doi. 10.3390/biom14010105
- By:
- Publication type:
- Article
VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-?B-dependent mechanism.
- Published in:
- Oncogene, 2005, v. 24, n. 9, p. 1563, doi. 10.1038/sj.onc.1208348
- By:
- Publication type:
- Article
Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-?B and JNK/AP1 pathways.
- Published in:
- Oncogene, 2003, v. 22, n. 22, p. 3371, doi. 10.1038/sj.onc.1206407
- By:
- Publication type:
- Article
Highlights in Prostate Cancer From the 2021 European Society for Medical Oncology Congress and the 2021 American Urological Association Meeting: Commentary.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 19
- By:
- Publication type:
- Article
High-Purity Prostate Circulating Tumor Cell Isolation by a Polymer Nanofiber-Embedded Microchip for Whole Exome Sequencing.
- Published in:
- Advanced Materials, 2013, v. 25, n. 21, p. 2897, doi. 10.1002/adma.201205237
- By:
- Publication type:
- Article
Tumor Cell Isolation: High-Purity Prostate Circulating Tumor Cell Isolation by a Polymer Nanofiber-Embedded Microchip for Whole Exome Sequencing (Adv. Mater. 21/2013).
- Published in:
- Advanced Materials, 2013, v. 25, n. 21, p. 2870, doi. 10.1002/adma.201370136
- By:
- Publication type:
- Article
Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 12, p. e2345906, doi. 10.1001/jamanetworkopen.2023.45906
- By:
- Publication type:
- Article
Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1271449
- By:
- Publication type:
- Article
An 89-Year-Old Man with COVID-19- Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor.
- Published in:
- American Journal of Case Reports, 2020, v. 21, p. 1, doi. 10.12659/AJCR.926728
- By:
- Publication type:
- Article
Impact of PSMA PET on Prostate Cancer Management.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 2, p. 191, doi. 10.1007/s11864-024-01181-9
- By:
- Publication type:
- Article
A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Molecules targeting the androgen receptor (AR) signaling axis beyond the AR‐Ligand binding domain.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 3, p. 910, doi. 10.1002/med.21548
- By:
- Publication type:
- Article
Cover Image, Volume 38, Issue 6.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 1, p. i, doi. 10.1002/med.21556
- By:
- Publication type:
- Article
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0451-z
- By:
- Publication type:
- Article
Prostate-Specific Membrane Antigen PET/CT-Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.124.267922
- By:
- Publication type:
- Article
RECIP 1.0 Predicts Progression-Free Survival After [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267234
- By:
- Publication type:
- Article
Differences and Common Ground in <sup>177</sup>Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266391
- By:
- Publication type:
- Article
RECIP 1.0 Predicts Progression-Free Survival After [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 917, doi. 10.2967/jnumed.123.267234
- By:
- Publication type:
- Article
Differences and Common Ground in <sup>177</sup>Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 438, doi. 10.2967/jnumed.123.266391
- By:
- Publication type:
- Article
Differences and Common Ground in <sup>177</sup>Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266391
- By:
- Publication type:
- Article
Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1737, doi. 10.2967/jnumed.122.265155
- By:
- Publication type:
- Article
Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1651, doi. 10.2967/jnumed.121.263072
- By:
- Publication type:
- Article
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263072
- By:
- Publication type:
- Article
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with 2 metastatic castration-resistant prostate cancer (RECIP 1.0): 3 an international multicenter study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263072
- By:
- Publication type:
- Article
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263072
- By:
- Publication type:
- Article
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263072
- By:
- Publication type:
- Article
aPROMISE: A Novel Automated-PROMISE platform to Standardize Evaluation of Tumor Burden in 18F-DCFPyL (PSMA) images of Veterans with Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.261863
- By:
- Publication type:
- Article
aPROMISE: A Novel Automated-PROMISE platform to Standardize Evaluation of Tumor Burden in <sup>18</sup>F-DCFPyL (PSMA) images of Veterans with Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.261863
- By:
- Publication type:
- Article
aPROMISE: A Novel Automated-PROMISE platform to Standardize Evaluation of Tumor Burden in 18F-DCFPyL (PSMA) images of Veterans with Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.261863
- By:
- Publication type:
- Article
aPROMISE: A Novel Automated-PROMISE platform to Standardize Evaluation of Tumor Burden in 18F-DCFPyL (PSMA) images of Veterans with Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.261863
- By:
- Publication type:
- Article
aPROMISE: A Novel Automated-PROMISE platform to Standardize Evaluation of Tumor Burden in 18F-DCFPyL (PSMA) images of Veterans with Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.261863
- By:
- Publication type:
- Article
aPROMISE: A Novel Automated-PROMISE platform to Standardize Evaluation of Tumor Burden in 18F-DCFPyL (PSMA) images of Veterans with Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.261863
- By:
- Publication type:
- Article
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single Center Study.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.237602
- By:
- Publication type:
- Article
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article